{"schema_version":"secwatch.filing_event.v1","accession":"0001697884-21-000011","form_type":"8-K","ticker":"VSBC","cik":"0001697884","company_name":"VITASPRING BIOMEDICAL CO. LTD.","filed_at":"2021-08-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:19.258465+00:00","generated_at":"2026-06-29T15:17:48.868072+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CEO Chu Pao-Chi resigns; Kao Cheng-Hsiang appointed CEO and retains Secretary role","bullets":["Chu Pao-Chi resigned as CEO effective August 7, 2020.","Kao Cheng-Hsiang, former secretary, appointed CEO and retains secretary position.","Chief Technical Officer Lin Jer-Li and Technical Vice-President Chen Yen Xun remain unchanged."],"urls":{"canonical":"https://secwatch.observer/filing/0001697884-21-000011","json":"https://secwatch.observer/filing/0001697884-21-000011.json","markdown":"https://secwatch.observer/filing/0001697884-21-000011.md","text":"https://secwatch.observer/filing/0001697884-21-000011.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1697884/000169788421000011/0001697884-21-000011-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1697884/000169788421000011/8kceochange.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T15:17:48.868072+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5b2f961f69","claim":"Kao Cheng-Hsiang was appointed as Chief Executive Officer at VITASPRING BIOMEDICAL CO. LTD..","evidence_excerpt":"current secretary of the Company, Kao Cheng-Hsiang, was appointed CEO and retains his position as Secretary.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1697884/000169788421000011/0001697884-21-000011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"bda774e922","claim":"Chu Pao-Chi resigned as Chief Executive Officer at VITASPRING BIOMEDICAL CO. LTD..","evidence_excerpt":"Effective August 7, 2020, Chu Pao-Chi Chairman of the Board of Directors, and Chief Executive Officer of the Company, resigned his position as CEO","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1697884/000169788421000011/0001697884-21-000011-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}